BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11260417)

  • 21. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.
    Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
    Adv Perit Dial; 1997; 13():17-22. PubMed ID: 9360644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group.
    Tranaeus A
    Perit Dial Int; 2000; 20(5):516-23. PubMed ID: 11117242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
    Mackenzie RK; Jones S; Moseley A; Holmes CJ; Argyle R; Williams JD; Coles GA; Pu K; Faict D; Topley N
    Am J Kidney Dis; 2000 Jan; 35(1):112-21. PubMed ID: 10620552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of transforming growth factor β1 during first six months of peritoneal dialysis.
    Stojimirović B; Jovanović N; Trbojević-Stanković J; Nešić DM; Brašanac T; Žunić-Božinovski S
    Ren Fail; 2015 May; 37(4):640-5. PubMed ID: 25682975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution.
    García H; Hernández-Jaras J; Cruz Mdel C; Agramunt I; Calvo C; Cerrillo V
    Perit Dial Int; 2003; 23(4):375-80. PubMed ID: 12968846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain.
    Mactier RA; Sprosen TS; Gokal R; Williams PF; Lindbergh M; Naik RB; Wrege U; Gröntoft KC; Larsson R; Berglund J; Tranaeus AP; Faict D
    Kidney Int; 1998 Apr; 53(4):1061-7. PubMed ID: 9551418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?
    Martikainen TA; Teppo AM; Grönhagen-Riska C; Ekstrand AV
    Perit Dial Int; 2005; 25(5):453-60. PubMed ID: 16178478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.
    Pajek J; Kveder R; Bren A; Gucek A; Bucar M; Skoberne A; Waniewski J; Lindholm B
    Nephrol Dial Transplant; 2009 May; 24(5):1617-25. PubMed ID: 19066345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis.
    Thongboonkerd V; Lumlertgul D; Supajatura V
    Artif Organs; 2001 Feb; 25(2):99-108. PubMed ID: 11251475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bicarbonate versus lactate buffer in peritoneal dialysis solutions: the beneficial effect on RBC metabolism.
    Buoncristiani U; Galli F; Rovidati S; Albertini MC; Covarelli C; Carobi C; Di Paolo N; Canestrari F
    Perit Dial Int; 1996; 16(5):511-8. PubMed ID: 8914181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
    Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
    Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients.
    Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M
    Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study.
    Martikainen T; Ekstrand A; Honkanen E; Teppo AM; Grönhagen-Riska C
    Scand J Urol Nephrol; 2005; 39(5):410-6. PubMed ID: 16257844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated peritoneal dialysis with 'on-line'-prepared bicarbonate-buffered dialysate: technique and first clinical experiences.
    Brunkhorst R; Fromm S; Wrenger E; Berke A; Petersen R; Riede G; Westphale J; Zamore E; Ledebo I
    Nephrol Dial Transplant; 1998 Dec; 13(12):3189-92. PubMed ID: 9870487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of pH-neutral peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
    Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.